Public disputes concerning abortion law and policy, including medication abortion, gestational limits, clinic access, funding, and the regulation of abortion drugs.
Published coverage on this page: 1 case · 4 statements. Statements are ordered newest first.
Senator Josh Hawley wants Congress to revoke the FDA's approval of mifepristone and ban the abortion pill nationally. His bill has stalled in committee, and in September he began pressing Republicans to sign a pledge backing it.
Published
Read the caseLabels describe a response to the linked claim or the action explained in the statement summary. Choose one or more.
4 matching statements
Role at the time: President and chief executive of the Planned Parenthood Action Fund, in a statement reported by MS NOW
Statement summary
Planned Parenthood Action Fund president and chief executive Alexis McGill Johnson condemned Hawley's bill as an attempt to restrict access to abortion care and to spread misinformation about mifepristone, which she described as a safe and effective medication used by millions.
“This is yet another effort from abortion opponents to restrict access to care and spread even more misinformation about a safe and effective medication that millions of people have used.”
What this label refers to
The case's fixed reference point is Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. McGill Johnson rejects the proposition and its evidentiary basis together. The closest competing label is challenges_characterization, since much of the sentence contests Hawley's factual account of the drug's safety. That loses because the passage also condemns the legislative effort itself as a restriction on care, which is a substantive rejection of the conduct under scrutiny and not merely a dispute about how the drug is described.
Role at the time: Senate Minority Leader and United States Senator for New York, in a statement to MS NOW
Statement summary
In a statement to MS NOW, Senate Minority Leader Chuck Schumer described Hawley's bill to revoke the FDA's approval of mifepristone as inconceivably cruel and radical.
“inconceivably cruel and radical”
What this label refers to
The case's fixed reference point is Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. Schumer's words are directed at that bill and reject it in the strongest terms. The closest competing label is minimizes, in the sense that dismissing a proposal as radical can work to place it outside serious debate rather than to argue against it. That loses because the characterisation is plainly condemnatory rather than a downplaying of anyone's concern, and it is addressed squarely at the legislation under scrutiny.
Role at the time: Obstetrician-gynecologist and president and chief executive of Physicians for Reproductive Health, in an organisational press release
Statement summary
Dr. Jamila Perritt, an obstetrician-gynecologist and president of Physicians for Reproductive Health, responded to Hawley's bill by stating that the scientific evidence establishes mifepristone as safe, effective and still medically indicated, using the same "the science is clear" construction Hawley had used to argue the opposite.
“the science is clear: mifepristone is safe, mifepristone is effective, and mifepristone is still medically indicated”
What this label refers to
The case's fixed reference point is Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. Perritt rejects the clinical premise the ban rests on, in a statement her organisation issued expressly as a response to the bill. The closest competing label is challenges_characterization, because on its face the sentence disputes a factual claim about the drug rather than addressing the legislation. That loses because the premise she rejects is the bill's sole stated justification, and the statement was issued as an objection to the bill; treating it as a narrow factual quarrel would understate a physicians' organisation's rejection of the proposal.
Role at the time: President and chief executive of Reproductive Freedom for All, in an organisational press release
Statement summary
Reproductive Freedom for All president and chief executive Mini Timmaraju condemned Hawley's bill, arguing that Missouri voters had themselves acted to protect abortion access and that the bill was a step toward a nationwide abortion ban.
“Let's not forget: Senator Hawley's own constituents voted to protect abortion access. But he and his extremist colleagues will not stop until they've banned abortion nationwide.”
What this label refers to
The case's fixed reference point is Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. Timmaraju rejects the proposition and characterises it as part of a broader national ban effort. The closest competing label is challenges_characterization, because she disputes Hawley's implicit claim to represent his constituents rather than arguing the pharmacology. That loses because the statement does not stop at contesting a description: it expressly rejects the legislative course itself as something that must be stopped.
United States Senator (Republican) from North Carolina.
1 case
United States Senator (Republican) from Alabama.
1 case
United States Representative and Republican candidate for U.S. House in Tennessee's 1st district.
1 case
United States Senator and Republican candidate for U.S. Senate in South Dakota.
1 case
Bernie Moreno is a Republican U.S. senator representing Ohio, serving in the Senate since 2025. Before entering elected office, he operated automobile dealerships in Ohio and co-founded CHAMP Titles, a company that develops digital vehicle-title systems.
1 case
